| Katarzyna Trebska, MD | |
|
685 S Dobson Rd, Chandler, AZ 85224-5665 | |
| (480) 821-2838 | |
| (480) 821-9444 |
| Full Name | Katarzyna Trebska |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 3 Years |
| Location | 685 S Dobson Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902198815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 62491 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ironwood Physicians Pc | 3577454842 | 101 |
News Archive
A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.
A team of Welsh academics has developed a new method of supporting health professionals to make clinical decisions about people who may be at risk of taking their own lives.
Tracking the subtle kidney damage that can lead to chronic kidney disease in HIV patients is increasingly important as people survive longer and may have an increased risk of renal dysfunction as a result of their disease, therapy-related damage, or co-morbid conditions such as diabetes mellitus and hypertension.
Dyax Corp. (NASDAQ:DYAX) today announced a study published evaluating the Company's novel Patient Reported Outcome Measures (PROs) used to assess hereditary angioedema (HAE) attacks affirmed the PROs as valuable instruments in capturing HAE symptom severity and impact of treatment.
› Verified 3 days ago
| Entity Name | Ironwood Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740269299 PECOS PAC ID: 3577454842 Enrollment ID: O20040324000807 |
News Archive
A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.
A team of Welsh academics has developed a new method of supporting health professionals to make clinical decisions about people who may be at risk of taking their own lives.
Tracking the subtle kidney damage that can lead to chronic kidney disease in HIV patients is increasingly important as people survive longer and may have an increased risk of renal dysfunction as a result of their disease, therapy-related damage, or co-morbid conditions such as diabetes mellitus and hypertension.
Dyax Corp. (NASDAQ:DYAX) today announced a study published evaluating the Company's novel Patient Reported Outcome Measures (PROs) used to assess hereditary angioedema (HAE) attacks affirmed the PROs as valuable instruments in capturing HAE symptom severity and impact of treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katarzyna Trebska, MD Po Box 6423, Chandler, AZ 85246-6423 Ph: (480) 821-2838 | Katarzyna Trebska, MD 685 S Dobson Rd, Chandler, AZ 85224-5665 Ph: (480) 821-2838 |
News Archive
A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.
A team of Welsh academics has developed a new method of supporting health professionals to make clinical decisions about people who may be at risk of taking their own lives.
Tracking the subtle kidney damage that can lead to chronic kidney disease in HIV patients is increasingly important as people survive longer and may have an increased risk of renal dysfunction as a result of their disease, therapy-related damage, or co-morbid conditions such as diabetes mellitus and hypertension.
Dyax Corp. (NASDAQ:DYAX) today announced a study published evaluating the Company's novel Patient Reported Outcome Measures (PROs) used to assess hereditary angioedema (HAE) attacks affirmed the PROs as valuable instruments in capturing HAE symptom severity and impact of treatment.
› Verified 3 days ago
Nicholas R Thiessen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 485 S Dobson Rd Ste 201, Chandler, AZ 85224 Phone: 480-728-4700 Fax: 480-728-4747 | |
Mark Gunst, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 485 S Dobson Rd, Suite 201, Chandler, AZ 85224 Phone: 480-728-4700 | |
Rohit K Sahai, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 963 N Mcqueen Road, Chandler, AZ 85225 Phone: 480-646-8440 Fax: 480-646-8441 | |
Dr. Laura R Champagne, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 685 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 | |
Dudley A Hudspeth, MD Surgery Medicare: Medicare Enrolled Practice Location: 485 S Dobson Rd, Ste 111, Chandler, AZ 85224 Phone: 480-407-4999 Fax: 480-407-4998 | |
Albert Wilson Harrison Iii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 485 S Dobson Rd Ste 115, Chandler, AZ 85224 Phone: 480-210-8620 Fax: 480-210-8622 | |
Paul L Vaughn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1940 N Alma School Rd, Chandler, AZ 85224 Phone: 480-890-0280 Fax: 480-890-2047 |